September 2018 Journal Club Meeting
Originally presented September 20, 2018
Presenters & Articles
Connie Suen, PharmD
PGY-2 Oncology Pharmacy Resident
Hospital of the University of Pennsylvania
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
Matthew Chui, PharmD
PGY2 Oncology Pharmacy Resident
University of Minnesota Health Cancer Center
Encorafenib plus binimetinib versus vemurafenib orencorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicenter, open-label, randomized phase 3 trial
This free event is open to HOPA members and non-members.
Listen to this webinar.